Dose History
30 total entries| Date & Time | Who | Peptide | Phase | Units | Dose | Notes |
|---|---|---|---|---|---|---|
| 2026-03-22T09:24 | Scott | Reta-Trutide | Phase 2 | 8 | 800 mcg (0.8 mg) | |
| 2026-03-22T09:24 | Grace | Reta-Trutide | Phase 2 | 7.5 | 750 mcg (0.75 mg) | |
| 2026-03-20T07:45 | Scott | KLOW | Phase 2 | 9 | ~264-330 mcg BPC/TB/KPV + ~1600-2000 mcg GHK-Cu | |
| 2026-03-19T05:40 | Scott | KLOW | Phase 2 | 10 | ~330 mcg BPC/TB/KPV + ~2000 mcg GHK-Cu | |
| 2026-03-18T07:58 | Scott | Reta-Trutide | Phase 2 | 8 | 800 mcg (0.8 mg) | |
| 2026-03-18T07:58 | Grace | Reta-Trutide | Phase 2 | 7.5 | 750 mcg (0.75 mg) | |
| 2026-03-18T07:57 | Scott | KLOW | Phase 1 | 6 | ~198 mcg BPC/TB/KPV + ~1200 mcg GHK-Cu | |
| 2026-03-17T05:00 | Scott | KLOW | Phase 1 | 6 | ~198 mcg BPC/TB/KPV + ~1200 mcg GHK-Cu | |
| 2026-03-16T22:12 | Scott | Ipamorelin + CJC-1295 | Phase 2 | 4 | ~132 mcg | |
| 2026-03-15T23:09 | Scott | Ipamorelin + CJC-1295 | Phase 2 | 5 | ~165 mcg | |
| 2026-03-15T09:20 | Scott | KLOW | Phase 1 | 5 | ~165 mcg BPC/TB/KPV + ~1000 mcg GHK-Cu | |
| 2026-03-15T09:20 | Scott | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-15T09:20 | Grace | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-14T09:39 | Scott | KLOW | Phase 1 | 5 | ~165 mcg BPC/TB/KPV + ~1000 mcg GHK-Cu | |
| 2026-03-11T08:37 | Scott | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-11T08:37 | Scott | KLOW | Phase 1 | 5 | ~165 mcg BPC/TB/KPV + ~1000 mcg GHK-Cu | |
| 2026-03-11T08:37 | Grace | Reta-Trutide | Phase 1 | 5 | 500 mcg (0.5 mg) | |
| 2026-03-10T22:20 | Scott | Ipamorelin + CJC-1295 | Phase 2 | 4 | ~132 mcg | |
| 2026-03-10T05:00 | Scott | KLOW | Phase 1 | 5 | ~165 mcg | |
| 2026-03-09T22:38 | Scott | Ipamorelin + CJC-1295 | Phase 2 | 3 | ~99 mcg |
Page 1 of 2 Next